ConductScience.org, home

Paper55271

Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.

Twentyman PR and 1 other. Br J Cancer, 1975. Cited by 47 papers, by iCite.

Cite this record

ConductScience Library. Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo. Papers, record 55271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/55271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Studies of "potentially lethal damage" in EMT6 mouse tumour cells treated with bleomycin either in vitro or in vivo.
PubMed
Journal
Br J Cancer
PubMed
Year
1975
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
47
iCite
Relative citation ratio, by iCite
2.64
iCite
Revised in PubMed
2019-05-15
PubMed

Authors2

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Twentyman PRP R
2Bleehen NMN M

Source PubMed

Download CSV of authors

Topics13

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BleomycinMajor topic
Neoplasms, ExperimentalMajor topic
Animals
Cell Line
Cell Survival
Cells, Cultured
Culture Media
Dose-Response Relationship, Drug
Methods
Mice
Temperature
Time Factors
Trypsin

Source PubMed

Download CSV of topics

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14121931Response of solid tumor cells exposed to chemotherapeutic agents in vivo: cell survival after 2- and 24-hour exposure.J Natl Cancer Inst1973https://conductscience.org/library/papers/4121931PubMed
24128424Cell survival and repair of plateau-phase cultures after chemotherapy--relevance to tumor therapy and to the in vitro screening of new agents.Cancer Chemother Rep1973https://conductscience.org/library/papers/4128424PubMed
34135125The effect of bleomycin and radiation in combination on bacteria and mammalian cells in culture.Br J Radiol1974https://conductscience.org/library/papers/4135125PubMed
44138662Radioautographic studies on the intracellular distribution of bleomycin-14C in mouse tumor cells.Cancer Res1974https://conductscience.org/library/papers/4138662PubMed
54138969Potentiation of bleomycin by an antifungal polyene, pentamycin, in transformed animal cells.Cancer Res1974https://conductscience.org/library/papers/4138969PubMed
64142871Demonstration of repair of potentially lethal damage in plateau phase cells of Ehrlich ascites tumor after exposure to bleomycin.Gan1974https://conductscience.org/library/papers/4142871PubMed
75793240Potentially lethal radiation damage: repair by mammalian cells in culture.Science1969https://conductscience.org/library/papers/5793240PubMed
84224300Repair of potentially lethal damage in x-irradiated HeLa cells.Radiat Res1966https://conductscience.org/library/papers/4224300PubMed
94647494Characteristics of a serially transplanted mouse mammary tumor and its tissue-culture-adapted derivative.J Natl Cancer Inst1972https://conductscience.org/library/papers/4647494PubMed
104678087Plateau-phase cultures of mammalian cells: an in vitro model for human cancer.Curr Top Radiat Res Q1972https://conductscience.org/library/papers/4678087PubMed
114684814Repair of potentially lethal radiation damage in vitro and in vivo.Radiology1973https://conductscience.org/library/papers/4684814PubMed
1247265Studies on recovery from chemically induced damage in mammalian cells.Cancer Res1975https://conductscience.org/library/papers/47265PubMed
135315187Repair of potentially-lethal radiation damage in mammalian cells: enhancement by conditioned medium from stationary cultures.Int J Radiat Biol Relat Stud Phys Chem Med1971https://conductscience.org/library/papers/5315187PubMed
144143273The sensitivity to bleomycin of a solid mouse tumour at different stages of growth.Br J Cancer1974https://conductscience.org/library/papers/4143273PubMed

Download CSV of references

Cited by15

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 47 citations.

PMIDTitleJournalYearIn PapersSource
7437290Response and recovery kinetics of a solid tumour after irradiation.Br J Cancer1980https://conductscience.org/library/papers/7437290PubMed
7387851Effects of local hyperthermia on the pharmacokinetics of misonidazole in the anaesthetized mouse.Br J Cancer1980https://conductscience.org/library/papers/7387851PubMed
6466543Preclinical pharmacokinetics of benznidazole.Br J Cancer1984https://conductscience.org/library/papers/6466543PubMed
6208924Inhibition of the recovery from potentially lethal damage by lonidamine.Br J Cancer1984https://conductscience.org/library/papers/6208924PubMed
6199035New type of recovery in HeLa cells exposed to bleomycin.Br J Cancer1984https://conductscience.org/library/papers/6199035PubMed
6177286Modulation of bleomycin cytotoxicity.Antimicrob Agents Chemother1982https://conductscience.org/library/papers/6177286PubMed
3940216CB 1954 revisited. I. Disposition kinetics and metabolism.Cancer Chemother Pharmacol1986https://conductscience.org/library/papers/3940216PubMed
921888Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea.Br J Cancer1977https://conductscience.org/library/papers/921888PubMed
856237Interaction of hyperthermia and the hypoxic cell sensitizer Ro-07-0582 on the EMT6 mouse tumour.Br J Cancer1977https://conductscience.org/library/papers/856237PubMed
836758Sensitivity to cytotoxic agents of the EMT6 tumour in vivo: tumour volume versus in vitro plating. 1. Cyclophosphamide.Br J Cancer1977https://conductscience.org/library/papers/836758PubMed
831758Separation of clonogenic tumour cells from EMT6 mouse mammary tumours.Br J Cancer1977https://conductscience.org/library/papers/831758PubMed
508562Effects of pretreatment with phenobarbitone and phenytoin on the pharmacokinetics and toxicity of phenytoin on the pharmacokinetics and toxicity of misonidazole in mice.Br J Cancer1979https://conductscience.org/library/papers/508562PubMed
73379An artefact in clonogenic assays of bleomycin cytotoxicity.Br J Cancer1977https://conductscience.org/library/papers/73379PubMed
72561Synergism of X-rays and bleomycin on Ehrlich ascites tumour cells.Br J Cancer1977https://conductscience.org/library/papers/72561PubMed
57788The sensitivity to cytotoxic agents of the EMT6 tumor in vivo. Comparative response of lung nodules in rapid expotential growth and of the solid flank tumour.Br J Cancer1976https://conductscience.org/library/papers/57788PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/55271

GET https://conductscience.org/api/papers/v1/55271/authors